1 / 4

US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023

The major players operating in the pharmaceutical industry consider outsourcing of the product manufacturing to contract manufacturing organizations. The contract manufacturers provide timely and cost-effective services, which in turn, enable the market players to focus on their core competencies.

larebomrglobal
Download Presentation

US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research US Pharmaceutical Contract Manufacturing Market: Industry Growth, Size, Share and Forecast 2019-2025 Request a free sample of our report on US Pharmaceutical Contract Manufacturing Market - Industry Size, Global Trends, Competitive https://www.omrglobal.com/request-sample/us-pharmaceutical-contract-manufacturing-market ------------------------------------------------------------------------------------ Analysis and Forecast, 2018-2023 Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The US pharmaceutical contract manufacturing market is growing at a significant rate of 6.8% during the forecast period (2019-2025). The US pharmaceutical contract manufacturing market is highly fragmented in nature. There are several small to medium companies that are providing pharmaceutical services on a contract basis to other firms. In recent years, the volume of generic drug sales has increased rapidly in the US, whereas, the outsourcing of branded pharmaceuticals in the US has been growing at a significant rate due to the lack of any production capacity constraint with pharmaceutical companies. A full report description of US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023 at https://www.omrglobal.com/industry-reports/us-pharmaceutical-contract- manufacturing-market A large number of branded pharmaceuticals have moved towards maturity and late growth stages in the product life cycle. Hence, utilization levels of these plants are likely to grow to unsustainable levels. This makes outsourcing a viable option for many pharmaceutical companies operating in the region. There are several major players in the market, which include Thermo Fisher Scientific, Inc., Catalent, Inc., Pfizer CenterOne, Baxter International, Inc., and AbbVie, Inc. Apart from these, various small players are operating in the market that are offering API, drug formulation, and other drug development and manufacturing services to pharmaceutical companies. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/us-pharmaceutical-contract-manufacturing-market For instance, Lief Organics and Paragon Laboratories are working as a contract manufacturer in finished dosage formulation. In addition, AbbVie, Inc. and Cambrex Corp. are offering contract manufacturing service for API. Therefore, the US pharmaceutical contract manufacturing market is highly diversified due to the presence of several small and large players that are offering different kinds of pharmaceutical manufacturing services. Mergers and acquisitions are key strategies adopted by market players operating in the US pharmaceutical contract manufacturing industry The companies providing pharmaceutical products and services in the US are actively seeking mergers and acquisitions as a key strategy over the last decades. Through mergers and acquisitions, a company can reduce the impact of a particular industry’s performance on its profitability. The companies seeking mergers and acquisitions often merge with companies that have deeper market penetration and expertise in a particular area of operation. This enables the company to have a strong foothold in that particular area and to strengthen its revenue stream.

  3. Significant mergers and acquisitions have been observed in the US pharmaceutical contract manufacturing market over the decades. For instance, in August 2017, Thermo Fisher Scientific Inc. acquired Patheon N.V., a CDMO for nearly $7.2 billion that serves the biotechnology and pharmaceutical sectors. This acquisition would enable the company to expand its contract manufacturing service for biotech and pharmaceutical firms. Moreover, in April 2019, Catalent, Inc. acquired Paragon Bioservices, Inc. for $1.2 billion. Paragon is a CDMO engaged in the development and production of biopharmaceuticals. This acquisition will enable to fundamentally increase the biologics business of Catalent and its end-to-end integrated biopharmaceutical solutions for customers. Visit here to know more about US Pharmaceutical Contract Manufacturing Market Current Market Trends Covered in the US Pharmaceutical Contract Manufacturing Market Report •Based on the category, the human-based drugs segment is estimated to hold a dominating market share during the forecast period. •Based on the product, API held the largest market share in the US pharmaceutical contract manufacturing market in 2018. •Based on the services, manufacturing services held the largest market share in the US pharmaceutical contract manufacturing market in 2018. US Pharmaceutical Contract Manufacturing Market Segmentation By Category •Animal-based Drugs •Human-based Drugs By Product •Active Pharmaceutical Ingredient •OTC Drugs •FDF •Others By Services •R&D •Manufacturing Services •Non-Clinical Services

  4. Key Players of Pharmaceutical Contract Manufacturing Market Report are: •Teva Pharmaceuticals •Piramal Pharma Solutions •Reddy’s Laboratories •Abbott Laboratories •Sun Pharmaceutical •Cobra Biologics •Ranbaxy Laboratories •MabPlex •Wockhardt •Cytovance Biologics About Orion Market Research Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404 Source: US Pharmaceutical Contract Manufacturing Market

More Related